Added to YB: 2026-01-19
Pitch date: 2025-11-17
NKTR [bullish]
Nektar Therapeutics
+0.07%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally.
Market Cap
$2.6B
Pitch Price
$59.19
Price Target
N/A
Dividend
N/A
EV/EBITDA
-17.11
P/E
-9.39
EV/Sales
35.49
Sector
Pharmaceuticals
Category
growth
Show full summary:
Nektar Therapeutics - $NKTR
NKTR: Derisked atopic dermatitis drug targeting $1.5-2.5B peak sales (~$2-2.5B NPV) backstops $1.2B market cap. Alopecia Ph2 readout end-2025 is free upside - mechanism sound, Reddit posts suggest efficacy in trial patients with injection site reactions. LLY acquisition rumors circulating.
Read full article (7 min)